Measure ID: MIPS 357·Patient Safety·2026 Performance Year

2026 MIPS Measure #357: Surgical Site Infection (SSI)

Percentage of patients aged 18 years and older who had a surgical site infection (SSI).

Outcome – High PriorityPatient SafetySurgery
Measure ID:MIPS 357 (Quality ID 357)
Collection:MIPS CQM
Topped Out:No
View CMS Spec ↗

Measure Specification

Eligible Population
All patients aged 18 years and older
ANDPatient procedure during the performance period
Exclusions

None

Numerator
Number of patients with a surgical site infection.
Reporting Codes

Performance Met:

Performance Not Met:

VBCA Insights

Why This Measure Matters

This measure tracks surgical site infections — wounds that become infected within 30 days after surgery. When your practice has a low rate of SSIs, it means your team is doing well with perioperative antibiotic prophylaxis, aseptic technique, and post-op wound care. Focus on timely pre-operative antibiotics, strict sterile field maintenance, and patient education about keeping the incision clean and dry. SSIs are painful for patients, extend hospital stays, and increase costs—preventing them through good technique saves everyone.

VBCA is a CMS-approved Qualified Clinical Data Registry (QCDR) that submits MIPS Measure 357 to the Quality Payment Program (QPP). Practices can report this measure as a MIPS Clinical Quality Measure (CQM) or through qualified registry submission.

🧮MIPS Score Simulator

Estimate only — actual CMS scoring may vary based on reporting method, data completeness, and annual rule updates.

%Benchmarks vary by collection type
💡 Tip: Enter your performance rate to compare MIPS points across all collection types. The same rate can score differently depending on how you submit.

2026 MIPS 357 Benchmarks

Historical CMS benchmark deciles for MIPS quality measure 357 by collection type. Your performance rate falls into a decile, which determines your measure points (3–10).

MIPS CQMAvg. performance rate: 0.18%
DecilePerformance Rate RangePoints
Decile 14.55 - 0.52%1 – 1.9
Decile 20.51 - 0.01%2 – 2.9
Decile 100.00%10

Related Measures

Patient Safety
MIPS 130: Documentation of Current Medications in the Medical RecordMIPS 145: Radiology: Exposure Dose Indices Reported for Procedures Using FluoroscopyMIPS 155: Falls: Plan of CareMIPS 164: Coronary Artery Bypass Graft (CABG): Prolonged IntubationMIPS 168: Coronary Artery Bypass Graft (CABG): Surgical Re-ExplorationMIPS 181: Elder Maltreatment Screen and Follow-Up PlanMIPS 259: Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-RupturedMIPS 275: Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status BeforeMIPS 286: Dementia: Safety Concern Screening and Follow-Up for Patients with DementiaMIPS 351: Total Knee or Hip Replacement: Venous Thromboembolic and Cardiovascular RiskMIPS 354: Anastomotic Leak InterventionMIPS 355: Unplanned Reoperation within the 30-Day Postoperative PeriodMIPS 374: Closing the Referral Loop: Receipt of Specialist ReportMIPS 384: Adult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the OperatingMIPS 385: Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity ImprovementMIPS 392: Cardiac Tamponade and/or Pericardiocentesis Following Atrial FibrillationMIPS 393: Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation,MIPS 413: Door to Puncture Time for Endovascular Stroke TreatmentMIPS 422: Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ ProlapseMIPS 432: Proportion of Patients Sustaining a Bladder or Bowel Injury at the time of any PelvicMIPS 513: Patient Reported Falls and Plan of Care

Clinical Context

Clinical Rationale

This is an adverse surgical outcome, which is often a preventable cause of harm, thus it is important to measure and report. It is feasible to collect the data and produce reliable and valid results about the quality of care. It is useful and understandable to stakeholders. This measure was developed in a collaborative effort by the American College of Surgeons and the American Board of Surgery.

This measure addresses the National Quality Strategy Priorities and was identified by an expert panel of physician providers to be a critical outcome for this procedure. This measure addresses a high-impact condition as it is one of the most common procedures performed in the U.S. The measure aligns well with the intended use. The care settings include Acute Care Facilities/Hospitals.

Data are being collected in a clinical registry that has been in existence for over 10 years, with over 5500 current, active users. Thus, we are requesting consideration of this measure in the MIPS CQM reporting option. The level of analysis is the clinician/individual. All populations are included, except children. The measure allows measurement across the person-centered episode of care out to 30 days after the procedure whether an inpatient, outpatient, or readmitted.

The measure addresses disparities in care. The risk adjustment is performed with a parsimonious dataset and aims to allow efficient data collection resources and data reporting. The measure has been harmonized when possible.

Clinical Recommendations

A modified-Delphi methodology using an expert panel of surgeons who are Directors of the American Board of Surgery identified this to be a critical outcome for this surgical procedure (Surgeon Specific Registry Report on Project for ABS MOC Part IV. Unpublished study by the American College of Surgeons in conjunction with the American Board of Surgery, 2011).

Implementation Notes

This measure contains one strata defined by a single submission criteria. This measure produces a single performance rate. For the purposes of MIPS implementation, this procedure measure is submitted each time a procedure is performed for the performance period. There is no diagnosis associated with this measure. All sites of the primary procedure and integral procedures performed during that trip to the operating room should be evaluated as part of this measure for possible wound occurrences.

If more than one SSI is observed, assign the SSI at the deepest level (superficial, deep or organ/space) that occurs within a 30-day postoperative timeframe. Include only patients that have procedures through November 30th of the performance period. This will allow the evaluation of at least 30 days after the surgical procedure within the performance period.

This is an inverse measure which means a lower calculated performance rate for this measure indicates better clinical care or control. The “Performance Not Met” numerator option for this measure is the representation of the better clinical quality or control. Submitting that numerator option will produce a performance rate that trends closer to 0%, as quality increases.

For inverse measures, a rate of 100% means all of the denominator eligible patients did not receive the appropriate care or were not in proper control.

Frequently Asked Questions

Who is eligible for MIPS 357?

Patients aged 18 years and older who have undergone a surgical procedure.

Is MIPS 357 the same as MIPS 357?

Yes. CMS uses zero-padded three-digit Quality IDs (357) in official specifications, while clinicians often search for MIPS 357 or Quality ID 357 without the leading zero. Both refer to the same 2026 MIPS quality measure reported through the Quality Payment Program (QPP).

What codes do I submit for MIPS 357: Surgical Site Infection (SSI)?

Submission codes: G9312 (Surgical site infection); G9311 (No surgical site infection)

How do I report MIPS Measure 357 in 2026?

MIPS Measure 357 (Quality ID 357) is reported through the Quality Payment Program (QPP) as a MIPS Clinical Quality Measure (CQM) via qualified registry, or Medicare Part B claims where applicable.

Is MIPS 357 a topped-out measure?

No, MIPS 357 is not topped out, meaning there is still meaningful performance variation across clinicians.

Report this measure through VBCA

Our QCDR handles measure selection, data validation, and submission—so you can focus on clinical performance.

Learn About Our QCDR →Talk to Us →

© 2013 - 2025 American College of Surgeons. All rights reserved.